Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +1.18%42 EBITDA Margin % is 36.57% as of Mar. 2026, which is 67% above its 10-year median of 21.94. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, Amwill Health Care ranks better than 98.31% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Amwill Health Care's EBITDA for the
six
months ended in Mar. 2026 was ₹88.8 Mil. Amwill Health Care's Revenue for the
six
months ended in Mar. 2026 was ₹242.9 Mil. Therefore, Amwill Health Care's EBITDA margin for the quarter that ended in Mar. 2026 was 36.57%.
Amwill Health Care (BOM:544353) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Amwill Health Care EBITDA Margin % Related Terms
Amwill Health Care EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544353 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Amwill Health Care's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amwill Health Care (BOM:544353) has a EBITDA Margin % of 36.57% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Amwill Health Care and its competitors. This is 67% above median its historical median of 21.94. According to the industry distribution chart, Amwill Health Care ranks #2 out of 118 companies in the Medical Distribution industry, placing it in the top 1.7%.
Is Amwill Health Care's EBITDA Margin % too high?
Amwill Health Care's current EBITDA Margin % of 36.57% is 67% above median its 10-year median of 21.94. The Medical Distribution industry median EBITDA Margin % is 4.16. Amwill Health Care's value of 36.57% is 780.1% above this industry median. Based on the distribution chart, Amwill Health Care ranks #2 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #2 out of 118 companies for EBITDA Margin %. This places Amwill Health Care in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.16. Amwill Health Care's value of 36.57% is 780.1% above this benchmark. While the company's 10-year median is 21.94 vs. the industry median of 4.16, Amwill Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.16, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current EBITDA Margin % of 36.57% is 780.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current EBITDA Margin % is 36.57%, which is 67% above median its own 10-year median of 21.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current EBITDA Margin % of 36.57%. The current EBITDA Margin % is 36.57%, which is 67% above median its 10-year median of 21.94 and 780.1% above the Medical Distribution industry median of 4.16. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current EBITDA Margin % is 36.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score
Get the complete analysis for BOM:544353
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
